TABLE 3.

Bivariate Analysis of Patients With and Without Diabetes

	Diabetes (n=33)	No Diabetes (n=85)	P
Recipient characteristics
Mean age at transplant	56.5±8.8	51.8±5.5	0.005
n (%) male	23 (69.7)	60 (70.6)	0.92
n (%) white	28 (84.9)	59 (69.4)	0.09
MELD	22.3±5.3	24.1±6.5	0.16
n with hypertension (%)	15 (45.5)	19 (22.3)	0.013
n with hyperlipidemia (%)	7 (21.2)	8 (9.4)	0.08
n with coronary artery disease (%)	1 (3.0)	4 (4.7)	0.69
n with hepatocellular carcinoma (%)	14 (42.4)	17 (20)	0.013
Mean body mass index	30.9±4.2	28.1±4.6	0.0036
Mean serum sodium	136±4.9	136±5.5	0.91
Mean creatinine	1.4±0.8	1.5±1.1	0.65
Donor characteristics
Male donors, n (%)	10 (33.3)	33 (41.8)	0.42
Donor age	36.8±14.2	36.0±15.8	0.81
Donor type
Deceased donor	29 (89)	78 (92)	0.27
DCD	3 (10)	7 (8)
Donor cause of death, n (%)
Anoxia	2 (7)	7 (9)	0.45
CVA	8 (28)	33 (42)
Trauma	19 (64)	37 (47)
Donor Risk Index	1.27±0.35	1.35±0.29	0.21
Operative characteristics
Warm ischemia time, min	39.7±6.1	40.9±12.6	0.60
Cold ischemia time, min	404±125	426±115	0.37
Required retransplant, n (%)	2 (6.1)	11 (12.9)	0.28
Survival
Graft survival, %
30 d	90.9	92.9	0.7183
1 y	78.2	83.5	0.5335
3 y	56.3	80.4	0.0632
Patient survival, %
30 d	90.1	96.5	0.2319
1 y	78.2	90.4	0.0765
3 y	63.3	88.9	0.0063
Patient cause of death, n (%)
Graft failure/1 liver disease*	2 (20)	0 (0)
Infection/sepsis	2 (20)	0 (0)
Cardiac	1 (10)	3 (33)	0.26
Biliary complication	1 (10)	2 (22)
Other	4 (40)*	4 (44)†

^*Hepatic artery thrombosis, multisystem organ failure, trauma, neuroendocrine tumor.

^†Hepatic artery thrombosis, hepatocellular carcinoma, graft versus host disease, multisystem organ failure.